Chernett Jorey 4

What Happened

• Chernett Jorey, reported as a 10% owner of Neuronetics, purchased a total of 1,057,400 shares in open-market/private transactions (transaction code P).
  • 2026-03-18: 607,400 shares at a weighted average price of $1.35 — $819,990.
  • 2026-03-19: 450,000 shares at a weighted average price of $1.33 — $598,500.
  • Combined purchase value ≈ $1,418,490.
• These were purchases (a net buy), which investors often view as a more informative/bullish signal than sales, though no motivation is stated.

Key Details

• Transaction dates: March 18, 2026 and March 19, 2026. Filings dated March 20, 2026 (appears timely under Form 4 rules).
• Prices: reported as weighted averages; footnotes state the shares were bought in multiple executions with price ranges of $1.33–$1.37 and $1.29–$1.48 (rounded to the nearest cent). The filer offers to provide a full breakdown of per-trade prices on request (per the footnotes).
• Shares owned after transaction: Not disclosed in the information provided in this summary — see the Form 4 for holdings after the trades.
• Transaction code: P = Purchase. No 10b5-1 plan, tax withholding, gifts, or option exercises noted in the provided details.

Context

• As a 10% owner, Chernett Jorey is a significant shareholder (not necessarily an executive). Large purchases by major holders can reflect increased conviction but do not by themselves prove future performance. This Form 4 records open-market acquisitions; no derivative exercises or immediate sales were reported.